Swallowable Capsule Could Transform Detection of Gastrointestinal Diseases
By HospiMedica International staff writers Posted on 21 Mar 2024 |
The conventional method for examining the intestines for gastrointestinal diseases involves an endoscopy, which uses a camera on a tube to identify visible issues. Capsule endoscopies, where patients swallow a capsule that sends images wirelessly, have marked a significant advancement. However, there is still no method to detect when the digestive tract is not working when it is not contracting and relaxing as it should when pushing waste along, and when there is no visible problem. Now, scientists have developed swallowable sensors to specifically identify gut movement problems, potentially revolutionizing the detection of gastrointestinal diseases and conditions.
A research team including scientists from the University of Birmingham (Birmingham, UK) has developed an ingestible capsule dotted with sensors that measure pressure within the gut to detect points of failure. Sized at 3 cm in length and 1 cm in diameter, the capsule is equipped with up to five ultra-thin sensors, each as thin as one or two human hairs. These pressure sensors are capable of monitoring the entire length of the gastrointestinal tract, about eight or nine meters, detecting zones of no movement, normal function, or unusual activity. Unlike traditional imaging, this capsule senses contractions as well as the amount of pressure exerted and identifies areas of inactivity.
Due to the number of sensors and flexibility, the device remains functional even if partially damaged. The scientists have ensured that the capsule does not harm the gut by using very thin sensors with a low-friction coating. They have also aimed to make the system both sustainable and cost-effective. This ingestible system can provide colorectal medical teams with unprecedented insight into a patient’s digestive tract movement or its absence. Although the system has been trialed in synthetic models and animals, it is anticipated that at least another five years of clinical trials will be required before this innovative product can be introduced to the market.
Related Links:
University of Birmingham
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure